newsfilter
← Latest News
GlobeNewswire·

Cellectis to Host Conference Call and Webcast on September 14 to Provide a Business Update

NEW YORK, Sept. 11, 2026 (GLOBE NEWSWIRE) -- Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene editing platform to develop life-saving cell and gene